Pre-Con I covers “Stroke in the Real World”

This day-long Pre-Conference Symposium of the International Stroke Conference takes place Tuesday, Feb. 5 and will provide the latest information for healthcare professionals caring for patients with, or at risk for stroke. This one-day symposium highlights scientific advances in cerebrovascular disease while emphasizing their application in the real world. The symposium informs the audience about issues along the full continuum of stroke care and covers varied topics of interest to healthcare providers working in the emergency department, hospitalist settings, primary care, general neurology, pharmacies, and other stroke care arenas.

This year’s symposium will focus on the rare causes of stroke including: identifying, distinguishing and a rheumatology perspective on CNS vasculitis; distinguishing vasculitis, vasospasm and atherosclerosis; mechanism of inherited small vessel ischemic lesions; neurocutaneous cause of stroke; endocarditis – treatment and indications for surgery; genetic collagen vasculopathies; interventions in FMD and moyamoya; MELAS; and stroke in the transgender patient. There will also be a series of challenging breakout sessions focusing on stroke in the cancer patient; stroke in pregnancy; and therapeutic challenges in treating infectious causes of Stroke including HIV, VZV, nematodes, tics, and fungal. Participants will also have the opportunity to have an informal lunch with the faculty where questions or challenging stroke cases may be discussed. (Please note you must register to attend the Pre-Conference Symposium.)

The learning objectives of this pre-conference include:

  • Discuss uncommon causes of stroke
  • Identify and differentiate CNS vasculitis
  • Propose treatment options for CNS vasculitis from a rheumatology perspective
  • Determine vasculitis, vasospasm and atherosclerosis
  • Define mechanisms of inherited small vessel ischemic lesions
  • Recognize neurocutaneous causes of stroke
  • Assess treatment for endocarditis including indications for surgery
  • Describe genetic collagen vasculopathies
  • Explain the perils and pitfalls in interventions in FMD and MoyaMoya
  • Describe MELAS from bench to bedside
  • Discuss stroke in the transgender patient
  • Manage stroke in the cancer patient
  • Recognize therapeutic challenges in treating infectious causes of stroke including HIV, VZV, nematodes, tics, and fungal
  • Document stroke in pregnancy
Top